The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments. IBM: International Business Machines . . . or “Incredible ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace ...

Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...

Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine.

Under the collaboration, Moderna will be part of the IBM Quantum Accelerator program as well as the IBM Quantum Network. Per the agreement, IBM will give Moderna access to quantum computing systems ...

Vaccine maker Moderna and computing giant IBM are teaming up to explore how quantum computing and artificial intelligence can develop future mRNA medicines, both companies announced on Thursday ...

Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.

Moderna recently signed a deal with International Business Machines (IBM 3.49%) to use quantum computing and AI to boost its messenger RNA research. Can this be a game changer for the company?

Boehringer will harness an AI model trained at IBM as the Big Pharma becomes the latest to apply machine learning tools to its drug development.

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing Covid shot does not currently face.

IBM and Moderna announced a new partnership today to explore the potential of generative AI and quantum computing.

Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM) today announced an agreement under which Moderna will explore ...